Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 13.
doi: 10.1097/ADM.0000000000001530. Online ahead of print.

Utilizing Decision Analysis to Assess the Safety of Providing Medication for Addiction Treatment to Professionals With Substance Use Disorder

Matthew Robert Dernbach, Lisa J Merlo, Robert L DuPont, Patrick R Krill, Quay Snyder, Anthony P Tvaryanas

Utilizing Decision Analysis to Assess the Safety of Providing Medication for Addiction Treatment to Professionals With Substance Use Disorder

Matthew Robert Dernbach et al. J Addict Med. .

Abstract

Care models for professionals with substance use disorder (SUD), such as those for physicians, attorneys, military personnel and commercial pilots, currently do not have a standard method to determine whether to allow medication for addiction treatment (MAT) in profession-specific treatment plans. The decision to endorse the use of MAT involves a tradeoff between maximizing SUD relapse prevention and minimizing MAT-related adverse effects that might impact safety. We propose a decision analysis process to facilitate an objective and evidence-based use of MAT in these circumstances. Already implemented in high-reliability sectors such as aviation, decision tree analysis of quantifiable hazards and mitigating variables can be used to calculate an evidence-based risk for the number of bad outcomes with one alternative versus another. Greater data transparency from and increased resource availability to professional care models are necessary to conduct and disseminate these analyses.

Keywords: addiction; decision analysis; professionals; risk management; substance use disorder.

PubMed Disclaimer

Conflict of interest statement

​L.J.M. currently serves as the Director of Research for the Professionals Resource Network, Inc. (the Florida physician health program). The remaining authors report no conflicts of interest.

References

    1. Reagan R Executive Order 12564—Drug-free Federal workplace. Accessed May 16, 2025. https://www.archives.gov/federal-register/codification/executive-order/1...
    1. Hazle MC, Saxon AJ, Hill KP. Buprenorphine in safety-sensitive positions. Am J Drug Alcohol Abuse. 2022;48(3):255–259.
    1. Federation of State Physician Health Programs, Inc. Position Statement: Safety Considerations for Medication Treatment of Opioid Use Disorders in Monitored Health Professionals. 2022. Accessed May 16, 2025. https://fsphp.memberclicks.net/assets/MEMBERPORTAL/FSPHP%20Safety%20Cons...
    1. Goldenberg M, Miotto K, Skipper GE, et al. Outcomes of physicians with substance use disorders in state physician health programs: a narrative review. J Psychoactive Drugs. 2020;52(3):195–202.
    1. Jaworski TJ. Letter of Findings: ADA Investigation Regarding the Tennessee Board of Law Examiners. US Department of Justice, United States Attorney, Middle District of Tennessee; 2024. USAO No. 2023V00171. Accessed May 16, 2025. https://www.justice.gov/crt/media/1380956/dl

LinkOut - more resources